SCOTUS Keeps Access to Mifepristone Abortion Pill Open
SCOTUS Keeps Access to Mifepristone Abortion Pill Open
The Facts
The US Supreme Court Thursday unanimously upheld access to abortion pill Mifepristone, rejecting arguments against the FDA making it easily available.
SCOTUS's first such ruling since Roe v. Wade's scrapping in 2022, said Mifepristone's opponents had no right to sue over FDA's nod for or easing of access to it.The US Supreme Court (SCOTUS) Thursday unanimously preserved access to the abortion pill Mifepristone.
The Spin
FDA's approval for Mifepristone in 2000 overlooked significant safety concerns, including those that put women at serious risk. All the more so when the pill is used without in-person examination. There is also an emotional and psychological toll, including trauma caused by the procedures. The regulator has ignored these risks, prioritizing access over well-being.
The FDA approved Mifepristone based on rigorous safety standards. It's now used in over half of all abortions nationwide. Allowing telemedicine prescriptions and mail delivery has only improved healthcare for women, especially in remote areas. Restricting access to it now will also potentially set a dangerous precedent where politics overrule science in healthcare decisions, causing real harm to women.
